Event Brief
May 6, 2026 at 7:05 AM ET
Hongkongers to pay HK$240 a year for leukaemia drug
By The BriefBrief
Hong Kong’s Hospital Authority began subsidising dasatinib in April, cutting patients’ annual cost to HK$240.
WHO: Hospital Authority
WHAT: Dasatinib reclassified and subsidised, reducing leukaemia drug payments to HK$240 a year
WHEN: May 6, 2026 at 6:34 AM ET
WHERE: Hong Kong
WHY: The Hospital Authority began subsidising the medication to reduce patients’ treatment costs.
Reporting from 1 identified publisher for this event.
View all 1 publishers
Publishers represented across this event arc
These publishers contributed reporting to the broader event history. Not every source addresses the specific development described above.
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
EU urged to act now on West Bank settlement project
Eu
May 6, 2026 at 7:05 AM ET
Former Russian insider: fear drove elites to back Putin
Putin
May 6, 2026 at 7:05 AM ET
Europe’s first robotaxi service launches in Croatia
Croatia
May 6, 2026 at 7:05 AM ET
Pope Leo to visit Canary Islands on Spain trip
Pope Leo
May 6, 2026 at 7:05 AM ET
Page 20482 of 21430
Same format. Every time.
Continue reading — sign in or create a free account with
